John Cipriano - 28 Jul 2025 Form 4 Insider Report for CEL SCI CORP (CVM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Jul 2025, 17:12:13 UTC
Prior SEC filing
10 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Cipriano

Key filing fact

John Cipriano filed Form 4 for CEL SCI CORP (CVM) on 29 Jul 2025.

Key facts

  • This page summarizes John Cipriano's Form 4 filing for CEL SCI CORP (CVM).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jul 2025, 17:12.

Change

  • Previous filing in this sequence was filed on 10 Aug 2023.
  • Current net transaction value: +$75.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001282304 Primary reporting owner

CIPRIANO JOHN

Relationship
Senior Vice President
Address
8229 BOONE BLVD, SUITE 802, VIENNA
Signature
John Cipriano
Signature date
29 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVM transaction Derivative

Options

Award

Transaction value
$75
Shares
+7,500
Change %
+25%
Price
$0.0100
Shares after
38,008
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,500
Exercise price
$8.20
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options vest in three (3) equal annual installments commencing one year after the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .